Tofersen
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 149 publications
Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study).
Journal: Mayo Clinic proceedings. Innovations, quality & outcomes
Published: August 04, 2026
SOD1-lowering therapy for patients with wildtype SOD1-ALS: a case report.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: July 22, 2026
An Intrathecal Therapeutics Clinic for Administration of Tofersen in Amyotrophic Lateral Sclerosis: A Canadian Nurse Practitioner and Neurologist Collaborative Model.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Published: July 13, 2026
Severe hypersensitivity reaction during tofersen therapy in amyotrophic lateral sclerosis associated with the rare SOD1 p.Val120Phe mutation.
Journal: Neurologia i neurochirurgia polska
Published: July 06, 2026
Update and recommendations on genetic testing for amyotrophic lateral sclerosis in clinical practice: a Brazilian expert view.
Journal: Frontiers in neurology
Published: July 04, 2026
Expanding the phenotypic spectrum of SOD1‑related ALS: upper motor neuron predominance in a p.D91A case.
Journal: Neurodegenerative disease management
Published: May 25, 2026
Therapeutic Challenges and Future Breakthroughs in Amyotrophic Lateral Sclerosis: From Precision Medicine to Innovative Trial Design.
Journal: Drug design, development and therapy
Published: May 19, 2026
Bridging the Funding Gap in Drug Development for Amyotrophic Lateral Sclerosis.
Journal: Neurology. Clinical practice
Published: May 11, 2026
Last Updated: 09/26/2026